In a remarkable turn of events, Altimmune (NASDAQ: ALT) witnessed a staggering 27% surge in its stock price this morning,…
Read More »Obesity
Structure Therapeutics (NASDAQ: GPCR) has seen a significant surge in pre-market trading, driven by several key factors that have captivated…
Read More »
ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, announced that Chief Executive Officer Jordan R. Plews, PhD has…
Read More »
ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, announced that Chief Executive Officer Dr. Jordan R. Plews, PhD…
Read More »
ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, has made significant strides of late with the launch of…
Read More »
Tesla (NASDAQ: TSLA) and SpaceX CEO Elon Musk has sparked a conversation about childhood obesity and potential solutions after giving…
Read More »
The agreement adds two drug candidates to the company’s product pipeline, “EL-22”, a clinical-stage engineered probiotic expressing myostatin, and “EL-32”,…
Read More »